Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003079018 | SCV003460717 | likely pathogenic | not provided | 2022-11-21 | criteria provided, single submitter | clinical testing | In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt USH2A protein function. This variant is present in population databases (rs756571385, gnomAD 0.02%). This missense change has been observed in individual(s) with retinitis pigmentosa and/or Usher syndrome (PMID: 29625443, 33090715). This sequence change replaces tyrosine, which is neutral and polar, with cysteine, which is neutral and slightly polar, at codon 2028 of the USH2A protein (p.Tyr2028Cys). |
Pangenia Genomics, |
RCV003226567 | SCV003922059 | uncertain significance | Retinitis pigmentosa 39 | 2022-03-14 | criteria provided, single submitter | research | The USH2A, c.6083A>G (p.Tyr2028Cys) variant is at extremely low frequency in population database; allele frequency in East Asia population is 0.0002 by gnomAD v2.1.1. This variant has been reported [PMID:30029497] to be detected in a retinitis pigmentosa patient, in trans with a known pathogenic variant [USH2A, c.2802T>G (p.Cys934Trp)]. Multiple lines of computational evidence support a deleterious effect on the gene/gene product (REVEL = 0.891). This variant is detected in trans with a variant of uncertain significance [USH2A, c.1625G>T (p.Ser542Ile)]. |
Genome- |
RCV003226567 | SCV004181718 | uncertain significance | Retinitis pigmentosa 39 | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003455690 | SCV004181719 | uncertain significance | Usher syndrome type 2A | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV003226567 | SCV004208168 | likely pathogenic | Retinitis pigmentosa 39 | 2024-03-17 | criteria provided, single submitter | clinical testing |